Skip to main content
. 2013 Sep;98(9):1407–1413. doi: 10.3324/haematol.2013.085167

Figure 1.

Figure 1.

Study flow. One hundred fifty-seven patients were recruited for the study. Five patients were excluded because MMR was not detect ed at the first testing. BCR-ABLIS 0.0032%–0.1% was detected in 69 of the 152 patients at the first testing, and these patients were classified into the No-CMR group. Seventy-five patients with BCR-ABLIS&lE0.0032% confirmed at the first and the second testing were classified into the CMR group. BCR-ABLIS&lE0.0032% was detected at the first testing but not confirmed in the second testing in eight patients, who were classified into the No-CMR group.